Background: Triple negative breast cancer category is a challenging group of breast cancer. It needs more detailed clinical and pathological studies.
CITATION STYLE
NAGLAA EL-KINAAI, M.D., A.-S. Z., M. Sc. ;, HANAN RAMADAN NASSAR, M.D., I. L., M. D. ;, MERVAT EL-DEFTAR, M.D., T. D., M. D. ;, & HASAN NABIL, M.D., R. M. A., M. D. ; (2018). Triple Negative Breast Cancer, Clinicopathologic Study of Egyptian Patients, NCI Experience. The Medical Journal of Cairo University, 86(9), 2747–2753. https://doi.org/10.21608/mjcu.2018.59615
Mendeley helps you to discover research relevant for your work.